Schemelev A, Davydenko V, Ostankova Y, Reingardt D, Serikova E, Zueva E
Viruses. 2024; 16(11).
PMID: 39599797
PMC: 11599013.
DOI: 10.3390/v16111682.
Roesmann F, Muller L, Klaassen K, Hess S, Widera M
Viruses. 2024; 16(6).
PMID: 38932230
PMC: 11209495.
DOI: 10.3390/v16060938.
Duchon A, Hu W
mBio. 2024; 15(4):e0086123.
PMID: 38411060
PMC: 11005445.
DOI: 10.1128/mbio.00861-23.
Gea-Mallorqui E, Rowland-Jones S
Immunother Adv. 2023; 3(1):ltad023.
PMID: 38020311
PMC: 10656295.
DOI: 10.1093/immadv/ltad023.
Spittler D, Indorato R, Boeri Erba E, Delaforge E, Signor L, Harris S
Life Sci Alliance. 2022; 5(10).
PMID: 35995566
PMC: 9396022.
DOI: 10.26508/lsa.202201431.
Human Retrovirus Genomic RNA Packaging.
Hanson H, Willkomm N, Yang H, Mansky L
Viruses. 2022; 14(5).
PMID: 35632835
PMC: 9142903.
DOI: 10.3390/v14051094.
The Interplay Among HIV, LINE-1, and the Interferon Signaling System.
Zhao X, Zhao Y, Du J, Gao P, Zhao K
Front Immunol. 2021; 12:732775.
PMID: 34566998
PMC: 8459832.
DOI: 10.3389/fimmu.2021.732775.
Let It Go: HIV-1 -Acting Repressive Sequences.
Ostermann P, Ritchie A, Ptok J, Schaal H
J Virol. 2021; 95(15):e0034221.
PMID: 33980600
PMC: 8274598.
DOI: 10.1128/JVI.00342-21.
HIV Rev-isited.
Truman C, Jarvelin A, Davis I, Castello A
Open Biol. 2020; 10(12):200320.
PMID: 33352061
PMC: 7776567.
DOI: 10.1098/rsob.200320.
Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8 T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency Reversal.
Mota T, McCann C, Danesh A, Huang S, Magat D, Ren Y
J Virol. 2020; 94(9).
PMID: 32051267
PMC: 7163115.
DOI: 10.1128/JVI.01845-19.
Structural Fluidity of the Human Immunodeficiency Virus Rev Response Element.
Sherpa C, Le Grice S
Viruses. 2020; 12(1).
PMID: 31940828
PMC: 7019801.
DOI: 10.3390/v12010086.
Sequence and Functional Variation in the HIV-1 Rev Regulatory Axis.
Jackson P, Dzhivhuho G, Rekosh D, Hammarskjold M
Curr HIV Res. 2020; 18(2):85-98.
PMID: 31906839
PMC: 7113094.
DOI: 10.2174/1570162X18666200106112842.
40 years of the human T-cell leukemia virus: past, present, and future.
Tagaya Y, Matsuoka M, Gallo R
F1000Res. 2019; 8.
PMID: 30854194
PMC: 6396841.
DOI: 10.12688/f1000research.17479.1.
Focus on Translation Initiation of the HIV-1 mRNAs.
de Breyne S, Ohlmann T
Int J Mol Sci. 2019; 20(1).
PMID: 30597859
PMC: 6337239.
DOI: 10.3390/ijms20010101.
A Rev-CBP80-eIF4AI complex drives Gag synthesis from the HIV-1 unspliced mRNA.
Toro-Ascuy D, Rojas-Araya B, Garcia-de-Gracia F, Rojas-Fuentes C, Pereira-Montecinos C, Gaete-Argel A
Nucleic Acids Res. 2018; 46(21):11539-11552.
PMID: 30239828
PMC: 6265489.
DOI: 10.1093/nar/gky851.
Structure of an RNA Aptamer that Can Inhibit HIV-1 by Blocking Rev-Cognate RNA (RRE) Binding and Rev-Rev Association.
Dearborn A, Eren E, Watts N, Palmer I, Kaufman J, Steven A
Structure. 2018; 26(9):1187-1195.e4.
PMID: 30017564
PMC: 7319042.
DOI: 10.1016/j.str.2018.06.001.
T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.
Thomas A, Jones K, Gandhi R, McMahon D, Cyktor J, Chan D
PLoS Pathog. 2017; 13(9):e1006629.
PMID: 28931091
PMC: 5624641.
DOI: 10.1371/journal.ppat.1006629.
Identification of a homogenous structural basis for oligomerization by retroviral Rev-like proteins.
Umunnakwe C, Dorman K, Dobbs D, Carpenter S
Retrovirology. 2017; 14(1):40.
PMID: 28830558
PMC: 5568270.
DOI: 10.1186/s12977-017-0366-1.
Oligomeric viral proteins: small in size, large in presence.
Jayaraman B, Smith A, Fernandes J, Frankel A
Crit Rev Biochem Mol Biol. 2016; 51(5):379-394.
PMID: 27685368
PMC: 5088105.
DOI: 10.1080/10409238.2016.1215406.
HIV DNA Vaccine: Stepwise Improvements Make a Difference.
Felber B, Valentin A, Rosati M, Bergamaschi C, Pavlakis G
Vaccines (Basel). 2015; 2(2):354-79.
PMID: 26344623
PMC: 4494255.
DOI: 10.3390/vaccines2020354.
